Unlock instant, AI-driven research and patent intelligence for your innovation.

Pharmaceutical composition for treating benign prostatic hyperplasia

A prostatic hyperplasia and composition technology, which is applied in the direction of drug combination, medical formula, plant raw materials, etc., can solve the problems of low mortality rate, patient damage, weak physiological function, etc., and achieve high cure rate, short course of treatment, and improvement of physical fitness Effect

Inactive Publication Date: 2014-12-17
石景花
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] At present, the treatment methods for benign prostatic hyperplasia are mainly divided into surgical treatment and drug treatment. Among them, surgical eradication is considered to be the first choice for the radical cure of BPH. Not high, but will still cause varying degrees of damage to patients

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical composition for treating benign prostatic hyperplasia
  • Pharmaceutical composition for treating benign prostatic hyperplasia
  • Pharmaceutical composition for treating benign prostatic hyperplasia

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0032] The preparation of embodiment 1 pharmaceutical granules of the present invention

[0033] Original decoction: Adults (calculated based on 60kg body weight) take one dose per day; decoct once in the morning and evening.

[0034] 1) Accurately weigh: 15g of Radix Paeoniae Rubra, 13g of Salvia miltiorrhiza, 5g of chrysanthemum, 5g of notopterygium, 10g of cassia twig, 12g of licorice, 15g of dodder, crushed separately, and mixed together;

[0035] 2) add 6 times the total weight of the raw material drug in water, reflux decocting for 2 hours, and filter to obtain filtrate a; add 3 times the total weight of the raw material drug in the filter residue, and then reflux decoct for 1.5 hours, and filter to obtain filtrate b; Mix the filtrates a and b, and concentrate under reduced pressure to obtain a dry cream powder for later use

[0036] 3) Mix the dry paste powder obtained in step 2) with 2 g of pine pollen evenly, add appropriate amount of auxiliary materials, granulate a...

Embodiment 2

[0037] The preparation of embodiment 2 pharmaceutical capsules of the present invention

[0038] Original decoction: Adults (calculated based on 60kg body weight) take one dose per day; decoct once in the morning and evening.

[0039] 1) Accurately weigh: 12g of Radix Paeoniae Rubra, 10g of Salvia miltiorrhiza, 3g of Shichenin, 4g of notopterygium, 9g of cassia twig, 10g of licorice, and 10g of dodder, respectively crushed and mixed together;

[0040] 2) Add 5 times the total weight of the raw material drug in water, reflux decocting for 1 hour, and filter to obtain filtrate a; add 3 times the total weight of the raw material drug in the filter residue, and then reflux decoct for 3 hours, and filter to obtain filtrate b; Mix the filtrates a and b, and concentrate under reduced pressure to obtain a dry cream powder for later use

[0041] 3) Mix the dry paste powder obtained in step 2) with 1 g of pine pollen evenly, add appropriate amount of auxiliary materials, and make capsu...

Embodiment 3

[0042] The preparation of embodiment 3 pharmaceutical tablet of the present invention

[0043] Original decoction: Adults (calculated based on 60kg body weight) take one dose per day; decoct once in the morning and evening.

[0044] 1) Accurately weigh: 18g of Radix Paeoniae Rubra, 16g of Salvia miltiorrhiza, 7g of chrysanthemum, 7g of notopterygium, 13g of cassia twig, 14g of licorice, 20g of dodder, crushed separately, and mixed together;

[0045] 2) adding 8 times the total weight of the raw material medicine in water, decocting under reflux for 3 hours, and filtering to obtain filtrate a; adding 4 times the total weight of the raw material medicine to the filter residue, and then reflux decocting for 3 hours, and filtering to obtain filtrate b; Mix the filtrates a and b, and concentrate under reduced pressure to obtain a dry cream powder for later use

[0046]3) Mix the dry paste powder obtained in step 2) with 3 g of pine pollen evenly, add appropriate amount of auxiliar...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a pharmaceutical composition for treating benign prostatic hyperplasia. The pharmaceutical composition is prepared from the following medicinal raw materials in parts by weight: 12-18 parts of common peony root, 10-16 parts of salvia miltiorrhiza, 3-7 parts of scabrous mosla herb, 4-7 parts of notopterygium root, 9-13 parts of cassia twig, 10-14 parts of liquorice, 10-20 parts of Chinese dodder seeds and 1-3 parts of pine pollen. Furthermore, the invention discloses a preparation method and application of the pharmaceutical composition. The pharmaceutical composition is free from toxic and side effect and has functions of soothing liver, regulating qi, warming kidneys, benefiting qi, dissolving stasis, clearing away heat and promoting diuresis; moreover, the pharmaceutical composition has the advantages of extra curative effect, short treatment course and high cure rate.

Description

technical field [0001] The invention belongs to the field of traditional Chinese medicines, in particular to a pharmaceutical composition for treating benign prostatic hyperplasia and a preparation method thereof. Background technique [0002] Benign prostatic hyperplasia (benign prostatic hyperplasia, BPH) is a common disease in middle-aged and elderly men. It usually begins to occur after the age of 40, and the incidence rate increases with age. According to relevant data, the incidence rate of BPH in 50-year-old men is over 50%, and the incidence rate of 80-year-old men is as high as 90%. The main clinical manifestations are frequent urination, urgency, and progressive dysuria, which can lead to complications such as urinary system infection, bladder stones, and hematuria, which have a serious impact on the quality of life of elderly men and must be actively treated. [0003] At present, the treatment methods for benign prostatic hyperplasia are mainly divided into surgi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/71A61P13/08
Inventor 陈远征
Owner 石景花